The global market for prefilled syringes is expanding, driven by the rising prevalence of chronic illnesses, greater use of biologics and biosimilars, and a growing trend toward self-injection.

Cold toes, color changes, and swelling could be early signs of poor circulation. Here's how your toes signal cardiovascular ...

The U.S. Food and Drug Administration has approved a prefilled syringe version of Netherlands-based Argenx SE's blockbuster ...

This market research report provides an in-depth analysis of the Injectable Drug Delivery Market, projecting significant ...

A new technology for management of diabetes is cost-effective for patients in the US with type 1 diabetes compared with traditional treatments.